ArticleBMC ophthalmology2026
Outcomes of primary orbital implantation in evisceration/enucleation in patients with endophthalmitis in a tertiary hospital.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the safety and outcomes of primary orbital implantation during evisceration/enucleation for endophthalmitis, specifically analyzing the risk of implant exposure/extrusion.
methodsRetrospective review of 98 endophthalmitis patients (90 eviscerations, 8 enucleations) who received a primary orbital implant (mostly PMMA) over 10 years. Follow-up averaged 27.5 months.
resultsPostoperative implant exposure/extrusion occurred in 10 patients (10.2%). This rate is comparable to established literature. The mean time to exposure was 140 days. Neither preoperative orbital cellulitis nor culture positivity (e.g., Pseudomonas) was statistically associated with a higher risk of exposure. Re-operations for exposure did not show evidence of active, ongoing infection.
conclusionPrimary orbital implantation in endophthalmitis patients is safe, carrying an exposure/extrusion risk (10.2%) comparable to reported rates. The procedure should be favored over a two-staged approach unless significant inflammation is noted intraoperatively. PRéCIS: The purpose of this paper is to study outcomes of primary orbital implantation in Endophthalmitis patient, and to review the exposure rate, and to also analyze possible risk factors for the exposure/extrusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.